SITC 2026 IO Drug Development SummitPlenary presentation of IPH5201 Phase 2 interim results at AACR 2026Abstract released: interim results from IPH5201 Phase 2 to be presented at AACR 2026AACR Annual Meeting 2026CICON 2024First patient dosed in Phase 2 MATISSE trial of IPH5201IPH5201 (CD39 mAb): initiation of Phase 2 clinical trial MATISSEIPH5201 (CD39 mAb) to advance into Phase 2Armand Bensussan awarded the Galien Prize 2020